{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:54:53Z","timestamp":1790384093589,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["58DP003862-01"],"award-info":[{"award-number":["58DP003862-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005002","name":"California Department of Public Health","doi-asserted-by":"publisher","award":["58DP003862-01"],"award-info":[{"award-number":["58DP003862-01"]}],"id":[{"id":"10.13039\/100005002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007174","name":"Pfizer Inc Boulder","doi-asserted-by":"publisher","award":["58DP003862-01"],"award-info":[{"award-number":["58DP003862-01"]}],"id":[{"id":"10.13039\/100007174","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.breast.2021.08.005","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T08:38:49Z","timestamp":1628843929000},"page":"367-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race"],"prefix":"10.1016","volume":"59","author":[{"given":"Jifang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenilee","family":"Cueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-9601","authenticated-orcid":false,"given":"Naomi Y.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8712-0299","authenticated-orcid":false,"given":"Kent F.","family":"Hoskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0632-6311","authenticated-orcid":false,"given":"Nadia A.","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemseged A.","family":"Asfaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin C.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanjali","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7744-3518","authenticated-orcid":false,"given":"Gregory S.","family":"Calip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest H.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.breast.2021.08.005_bib1","first-page":"363","article-title":"Cancer treatment and survivorship statistics","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2021.08.005_bib2","series-title":"Breast cancer facts & figures 2019-2020","year":"2019"},{"issue":"6","key":"10.1016\/j.breast.2021.08.005_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1158\/1055-9965.EPI-16-0889","article-title":"Estimation of the number of women living with metastatic breast cancer in the United States","volume":"26","author":"Mariotto","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"10.1016\/j.breast.2021.08.005_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/jgs.15934","article-title":"Longitudinal relationship between frailty and cognition in patients 50 Years and older with breast cancer","volume":"67","author":"Magnuson","year":"2019","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.breast.2021.08.005_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10549-017-4222-8","article-title":"Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance)","volume":"164","author":"Mandelblatt","year":"2017","journal-title":"Breast Canc Res Treat"},{"issue":"9804","key":"10.1016\/j.breast.2021.08.005_bib6","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Early Breast Cancer Trialists' Collaborative","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.breast.2021.08.005_bib7","first-page":"1065","article-title":"Associations between diabetes medication use and risk of second breast cancer events and mortality","volume":"26","author":"Calip","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.breast.2021.08.005_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10549-013-2816-3","article-title":"Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors","volume":"143","author":"Wirtz","year":"2014","journal-title":"Breast Canc Res Treat"},{"issue":"2","key":"10.1016\/j.breast.2021.08.005_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-014-2870-5","article-title":"Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer","volume":"144","author":"Boudreau","year":"2014","journal-title":"Breast Canc Res Treat"},{"issue":"9","key":"10.1016\/j.breast.2021.08.005_bib10","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1158\/1055-9965.EPI-13-0454","article-title":"Frequent antibiotic use and second breast cancer events","volume":"22","author":"Wirtz","year":"2013","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"10.1016\/j.breast.2021.08.005_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/aje\/kww242","article-title":"Evidence for detection bias by medication use in a cohort study of breast cancer survivors","volume":"185","author":"Wirtz","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.breast.2021.08.005_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1200\/JOP.2011.000460","article-title":"Multimorbidity: an issue of growing importance for oncologists","volume":"7","author":"Ritchie","year":"2011","journal-title":"J\u00a0Oncol Pract"},{"issue":"8 Suppl","key":"10.1016\/j.breast.2021.08.005_bib13","first-page":"3","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"issue":"12","key":"10.1016\/j.breast.2021.08.005_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jnci\/djs233","article-title":"Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer","volume":"104","author":"Chubak","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2021.08.005_bib15","article-title":"An electronic health record-based algorithm to ascertain the date of second breast cancer events","author":"Chubak","year":"2015","journal-title":"Med Care"},{"issue":"19","key":"10.1016\/j.breast.2021.08.005_bib16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/jnci\/djt211","article-title":"Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival","volume":"105","author":"Chubak","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"21","key":"10.1016\/j.breast.2021.08.005_bib17","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1158\/0008-5472.CAN-17-0687","article-title":"Diabetes treatments and risks of adverse breast cancer outcomes among early-stage breast cancer patients: a SEER-medicare analysis","volume":"77","author":"Chen","year":"2017","journal-title":"Can Res"},{"issue":"11","key":"10.1016\/j.breast.2021.08.005_bib18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1158\/1055-9965.EPI-17-0346","article-title":"Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-medicare population","volume":"26","author":"Chen","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"10.1016\/j.breast.2021.08.005_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.annepidem.2007.03.011","article-title":"A\u00a0refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients","volume":"17","author":"Klabunde","year":"2007","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.breast.2021.08.005_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2015.09.022","article-title":"Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy","volume":"53","author":"Marme","year":"2016","journal-title":"Eur J Canc"},{"issue":"7","key":"10.1016\/j.breast.2021.08.005_bib21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/gerona\/glx229","article-title":"Measuring frailty in Medicare data: development and validation of a claims-based frailty index","volume":"73","author":"Kim","year":"2018","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.breast.2021.08.005_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2318-8-24","article-title":"A\u00a0standard procedure for creating a frailty index","volume":"8","author":"Searle","year":"2008","journal-title":"BMC Geriatr"},{"issue":"6","key":"10.1016\/j.breast.2021.08.005_bib23","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1532-5415.2006.00738.x","article-title":"Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70","volume":"54","author":"Rockwood","year":"2006","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"24","key":"10.1016\/j.breast.2021.08.005_bib24","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1002\/cncr.30269","article-title":"Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy","volume":"122","author":"Cohen","year":"2016","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.breast.2021.08.005_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.breast.2021.08.005_bib26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"446","key":"10.1016\/j.breast.2021.08.005_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"19","key":"10.1016\/j.breast.2021.08.005_bib28","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.breast.2021.08.005_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10549-017-4636-3","article-title":"20-year risk of breast cancer recurrence","volume":"168","author":"Kostev","year":"2018","journal-title":"Breast Canc Res Treat"},{"issue":"22","key":"10.1016\/j.breast.2021.08.005_bib30","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1200\/JCO.2012.46.1558","article-title":"Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy","volume":"31","author":"Dowsett","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"32","key":"10.1016\/j.breast.2021.08.005_bib31","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1200\/JCO.2010.31.2835","article-title":"Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer","volume":"29","author":"Cuzick","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.breast.2021.08.005_bib32","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1200\/JCO.2009.24.4798","article-title":"Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study","volume":"28","author":"Dowsett","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2021.08.005_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/SLA.0000000000001930","article-title":"Local recurrence and breast oncological surgery in young women with breast cancer: the POSH observational cohort study","volume":"266","author":"Maishman","year":"2017","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.breast.2021.08.005_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10549-014-3157-6","article-title":"Metabolic syndrome and outcomes following early-stage breast cancer","volume":"148","author":"Calip","year":"2014","journal-title":"Breast Canc Res Treat"},{"issue":"5","key":"10.1016\/j.breast.2021.08.005_bib35","first-page":"709","article-title":"Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study","volume":"27","author":"Calip","year":"2016","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.breast.2021.08.005_bib36","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1532-5415.2005.00467.x","article-title":"Treatment for breast cancer in patients with Alzheimer's disease","volume":"53","author":"Gorin","year":"2005","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.breast.2021.08.005_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamaoncol.2016.3931","article-title":"Surveillance mammography in older patients with breast cancer-can we ever stop?: a review","volume":"3","author":"Freedman","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.breast.2021.08.005_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jgo.2016.06.003","article-title":"How should older adults with cancer be evaluated for frailty?","volume":"8","author":"Huisingh-Scheetz","year":"2017","journal-title":"J\u00a0Geriatr Oncol"},{"key":"10.1016\/j.breast.2021.08.005_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s40520-019-01362-9","article-title":"Frailty and diabetes status in older patients with cancer: impact on mortality in the ANCRAGE cohort","author":"Liuu","year":"2020","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"10.1016\/j.breast.2021.08.005_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejso.2019.08.011","article-title":"Addressing frailty in patients with breast cancer: a review of the literature","volume":"46","author":"Jauhari","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2021.08.005_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju055","article-title":"US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status","volume":"106","author":"Howlader","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.breast.2021.08.005_bib42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/1940-6207.CAPR-11-0447","article-title":"A\u00a0review of cancer in U.S. Hispanic populations","volume":"5","author":"Haile","year":"2012","journal-title":"Canc Prev Res"},{"issue":"Suppl 3","key":"10.1016\/j.breast.2021.08.005_bib43","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.2105\/AJPH.2013.301673","article-title":"Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States","volume":"104","author":"White","year":"2014","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.breast.2021.08.005_bib44","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.5672","article-title":"Association of insurance status and racial disparities with the detection of early-stage breast cancer","author":"Ko","year":"2020","journal-title":"JAMA Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977621004343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977621004343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:46:49Z","timestamp":1760777209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977621004343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":44,"alternative-id":["S0960977621004343"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2021.08.005","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2021.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}